Centre For Cellular And Molecular Platforms, a active private not for profit company, was established on 08 January 2010 in Bangalore, Karnataka, India. Engaging in technical within the professional, scientific and technical sector, it holds CIN: U73200KA2010NPL052117. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 K and a paid-up capital of ₹1.00 K .
It upholds a compliant status. Its leadership includes Shashidhara Subrahmanya Lingadahalli (Director), Satyajit Satyapal Mayor (Director), Taslimarif Turabmiya Saiyed (Ceo). Past directors included Shashidhara Subrahmanya Lingadahalli, Vijayraghavan Krishnaswamy, Manoj Kumar. Its latest AGM occurred on 10 September 2025, with the balance sheet filed on 31 March 2025. It is based at Gkvk Po Bellary Road, Bangalore, Karnataka, 560065.
U73200KA2010NPL052117
052117
08 January 2010
₹1.00 K
₹1.00 K
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Centre For Cellular And Molecular Platforms — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shashidhara Subrahmanya Lingadahalli | Director | 21 Sep 2024 | Current |
| Satyajit Satyapal Mayor | Director | 08 Jan 2010 | Current |
| Taslimarif Turabmiya Saiyed | Ceo | 21 Apr 2017 | Current |
| Shrikumar Suryanarayan | Director | 19 Mar 2010 | Current |
| Manoj Kumar | Director | 20 Sep 2019 | Current |
| Subramanian Ramaswamy | Director | 19 Mar 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 23 Sep 2024 | Past |
| Pramod Abcsdd | Director | 22 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 23 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Centre For Cellular And Molecular Platforms, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Centre For Cellular And Molecular Platforms had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Centre For Cellular And Molecular Platforms, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Centre For Cellular And Molecular Platforms, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Centre For Cellular And Molecular Platforms's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Centre For Cellular And Molecular Platforms last Annual general meeting of members was held on 10 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Centre For Cellular And Molecular Platforms has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was completed.
Progress on Shashidhara Subrahmanya Lingadahalli was appointed as a Director was appointed as a Director on 21 Sep 2024 & has been associated with this company since 1 year 2 months . was documented.
The activity Manoj Kumar was appointed as a Director was appointed as a Director on 20 Sep 2019 & has been associated with this company since 6 years 2 months . was completed.
The activity Taslimarif Turabmiya Saiyed was appointed as a CEO was appointed as a CEO on 21 Apr 2017 & has been associated with this company since 8 years 7 months . was completed.
Taslimarif Turabmiya Saiyed was appointed as a CEO was appointed as a CEO on 21 Apr 2017 & has been associated with this company since 8 years 7 months . was recorded as a recent event.
Assam gov't and C-CAMP team up to improve public healthcare. MoU signed for tech adoption, infrastructure upgrades, and capacity-building. Projects include respiratory support, vaccine carriers, and oxygen-supported hospital. Goal: better healthcare for all, especially in areas like cancer screening. Let's work together for a healthier Assam!.
Janitri provides advanced wearables and solutions for pregnancy and labor vitals monitoring..
The CIN of Centre For Cellular And Molecular Platforms is U73200KA2010NPL052117.
Centre For Cellular And Molecular Platforms is headquartered at Gkvk Po Bellary Road, Bangalore, Karnataka, 560065.
Centre For Cellular And Molecular Platforms was incorporated on 08 January 2010.
The current directors of Centre For Cellular And Molecular Platforms are
The primary industry of Centre For Cellular And Molecular Platforms is Professional, Scientific And Technical.
Centre For Cellular And Molecular Platforms is unlisted.
The authorized capital of Centre For Cellular And Molecular Platforms is ₹1.00 K , and the paid-up capital is ₹1.00 K .
The compliance status of Centre For Cellular And Molecular Platforms is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX